The U.S. Supreme Court's decision to strike down the federal government's ban on offensive trademark registrations in a case involving rock band The Slants highlights just how little the provision fit into the overall confusion-preventing goals of the Lanham Act — and probably doomed similar rules, experts say.
A shoe company has filed a lawsuit in the U.S. District Court for the District of Massachusetts against a designer it says infringed on its trademarks and engaged in unfair trade practices.
South Korea has formally protested Japan’s ban on imports of Samsung SDI's plasma display panel screens, as patent litigation between Samsung and Fujitsu threatens to escalate to a trade dispute between the two countries.
A German parliamentary group has postponed the completion of a list of patent-protected drugs for which public health insurers will pay fixed prices.
The U.S. Court of Appeals for the Federal Circuit will hear the appeal in the closely observed dispute between Research in Motion and NTP over the patents covering Blackberry devices on June 7.
The merger between Hale and Dorr and Wilmer Cutler Pickering will bring together two intellectual property practices with little overlap and no significant conflicts of interests.
John Gould, one of the best-known practicing patent attorneys in the U.S., has marked his 50th anniversary with the firm that bears his name, Merchant & Gould.
German chip maker Infineon Technologies AG has filed a lawsuit against the University of Wisconsin seeking a declaration of noninfringement in a dispute over a patent for a process used in making semiconductors.
Gun maker Colt Defense has sued rivals Bushmaster and Heckler & Koch for trademark infringement, claiming the two companies have copied its best-selling weapon.
Miriam Beezy has joined Foley & Lardner LLP as a partner in the firm’s intellectual property department and leader of the national trademark and copyright practice group.
Canada has amended proposed legislation to allow domestic drug-makers to export generic copies of patented HIV/AIDS drugs to the developing world, stripping patent holders of the “right of first refusal'” over contracts negotiated between developing countries and Canadian generics manufacturers.
Israel’s cabinet, under pressure from U.S. trade officials, is expected to approve recommendations for drug marketing exclusivity on Sunday, according to a local newspaper report.
In a surprise decision, Russia has adopted amendments to the copyright law that extend copyright protection to 70 years after the author’s death from the current 50 years.
Japanese customs authorities on Wednesday began blocking imports of plasma-display panels manufactured by a Samsung Group company on a request from Fujitsu in a dispute over patent rights.
Advocacy group Electronic Frontier Foundation has launched a campaign to identify “illegitimate” business method patents and file challenges to each in the form of a “re-examination request” to the U.S. Patent and Trademark Office.
A group of prominent U.S. Senators, including Republican John McCain and Democrat Edward Kennedy, unveiled Wednesday a bill that would legalize the importation of approved drugs from Canada and Europe.
Rail transport builder National Steel Car has agreed to drop its patent litigation against rival Greenbrier and its customer, Pacific Railway, in a dispute over a railcar patent.
Toymaker Mattel Inc. is entitled to copyright protection for the facial features of the Barbie doll, the 2nd U.S. Circuit Court of Appeals has determined in a ruling that overturned a lower court’s decision.
Software maker Portrait Displays has filed a copyright infringement and trade secrets misappropriation lawsuit in the U.S. District Court for the Northern District of California against EnTech Taiwan and two EnTech employees.
Japanese drug maker Sankyo has filed a lawsuit against domestic rival Nissin Pharmaceutical over its flagship hyperlipidaemia drug Mevalotin (pravastatin), which Sankyo developed after discovering the world’s first cholesterol inhibitor.
A new technology industry working group will counsel the U.S. government on making the patent system more responsive to technical innovation, FTC Commissioner Mozelle Thompson announced Friday at a high-level conference on patent reform at the University of California.